Cash Flow Statement

Acquisitions Amortization Amortization Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Depreciation Expense EBIAT Leases Machine, Furnitures, Fixtures & Other Non-Current Receivables Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Receivables Refunds Shares Issued Shares Outstanding Shares Outstanding Wages, Salaries and Other

AC Immune (ACIU) Long-Term Debt Issuances (2017 - 2019)

AC Immune has reported Long-Term Debt Issuances over the past 3 years, most recently at $99017.6 for Q4 2019.

Quarterly Long-Term Debt Issuances rose 97.08% to $99017.6 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $539354.9 through Dec 2019, changed N/A year-over-year, with the annual reading at $25.7 million for FY2021, N/A changed from the prior year.
Long-Term Debt Issuances was $99017.6 for Q4 2019 at AC Immune, up from -$50.0 million in the prior quarter.
Over five years, Long-Term Debt Issuances peaked at $103.9 million in Q3 2017 and troughed at -$101.2 million in Q4 2017.
The 3-year median for Long-Term Debt Issuances is $74629.7 (2018), against an average of $551911.8.
Year-over-year, Long-Term Debt Issuances skyrocketed 100.05% in 2018 and then soared 97.08% in 2019.
A 3-year view of Long-Term Debt Issuances shows it stood at -$101.2 million in 2017, then skyrocketed by 100.05% to $50241.7 in 2018, then soared by 97.08% to $99017.6 in 2019.
Per Business Quant, the three most recent readings for ACIU's Long-Term Debt Issuances are $99017.6 (Q4 2019), -$50.0 million (Q2 2019), and $50.5 million (Q1 2019).